PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.19%
Revenue growth above 1.5x 3088.T's 2.40%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
2.25%
Gross profit growth at 75-90% of 3088.T's 2.84%. Bill Ackman would demand operational improvements to match competitor gains.
4.51%
EBIT growth below 50% of 3088.T's 25.32%. Michael Burry would suspect deeper competitive or cost structure issues.
4.40%
Operating income growth at 50-75% of 3088.T's 7.30%. Martin Whitman would doubt the firm’s ability to compete efficiently.
-2.80%
Negative net income growth while 3088.T stands at 14.56%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-2.81%
Negative EPS growth while 3088.T is at 17.81%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-2.81%
Negative diluted EPS growth while 3088.T is at 17.81%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 3088.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3088.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
55.34%
10Y revenue/share CAGR above 1.5x 3088.T's 8.96%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
55.34%
5Y revenue/share CAGR above 1.5x 3088.T's 8.96%. David Dodd would look for consistent product or market expansions fueling outperformance.
55.34%
3Y revenue/share CAGR above 1.5x 3088.T's 8.96%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
152.68%
Net income/share CAGR above 1.5x 3088.T's 16.27% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
152.68%
5Y net income/share CAGR above 1.5x 3088.T's 16.27%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
152.68%
3Y net income/share CAGR above 1.5x 3088.T's 16.27%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
82.37%
10Y equity/share CAGR above 1.5x 3088.T's 17.80%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
82.37%
5Y equity/share CAGR above 1.5x 3088.T's 17.80%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
82.37%
3Y equity/share CAGR above 1.5x 3088.T's 17.80%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.19%
Inventory is declining while 3088.T stands at 3.29%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.57%
Negative asset growth while 3088.T invests at 2.32%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.07%
BV/share growth above 1.5x 3088.T's 1.87%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-13.18%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.